VYNE Therapeutics Inc (VYNE)
2.55
0.00 (0.00%)
USD |
NASDAQ |
May 31, 16:00
2.63
+0.08
(+3.14%)
After-Hours: 20:00
VYNE Therapeutics Price: 2.55 for May 31, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
May 31, 2024 | 2.596 | 2.66 | 2.510 | 2.55 | 32553.00 |
May 30, 2024 | 2.56 | 2.59 | 2.50 | 2.55 | 47516.00 |
May 29, 2024 | 2.57 | 2.575 | 2.423 | 2.53 | 67284.00 |
May 28, 2024 | 2.51 | 2.621 | 2.50 | 2.590 | 17089.00 |
May 24, 2024 | 2.65 | 2.65 | 2.51 | 2.58 | 22666.00 |
May 23, 2024 | 2.72 | 2.75 | 2.58 | 2.63 | 27073.00 |
May 22, 2024 | 2.67 | 2.74 | 2.650 | 2.66 | 19891.00 |
May 21, 2024 | 2.722 | 2.730 | 2.650 | 2.70 | 14814.00 |
May 20, 2024 | 2.80 | 2.850 | 2.73 | 2.73 | 10166.00 |
May 17, 2024 | 2.70 | 2.84 | 2.70 | 2.77 | 33346.00 |
May 16, 2024 | 2.844 | 2.844 | 2.67 | 2.70 | 17838.00 |
May 15, 2024 | 2.923 | 3.00 | 2.748 | 2.76 | 31661.00 |
May 14, 2024 | 2.86 | 2.97 | 2.83 | 2.89 | 34007.00 |
May 13, 2024 | 2.67 | 2.854 | 2.67 | 2.83 | 109853.0 |
May 10, 2024 | 2.67 | 2.770 | 2.65 | 2.67 | 23067.00 |
May 09, 2024 | 2.77 | 2.77 | 2.56 | 2.65 | 42984.00 |
May 08, 2024 | 2.86 | 2.92 | 2.660 | 2.72 | 30744.00 |
May 07, 2024 | 2.74 | 3.10 | 2.71 | 2.89 | 120121.0 |
May 06, 2024 | 2.64 | 2.750 | 2.580 | 2.71 | 35748.00 |
May 03, 2024 | 2.54 | 2.768 | 2.53 | 2.62 | 34681.00 |
May 02, 2024 | 2.53 | 2.53 | 2.40 | 2.50 | 29242.00 |
May 01, 2024 | 2.50 | 2.57 | 2.50 | 2.53 | 83588.00 |
Apr 30, 2024 | 2.61 | 2.61 | 2.40 | 2.52 | 39454.00 |
Apr 29, 2024 | 2.54 | 2.63 | 2.530 | 2.63 | 19253.00 |
Apr 26, 2024 | 2.53 | 2.575 | 2.42 | 2.50 | 15899.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
1.71
Minimum
Jan 31 2024
499.68
Maximum
Jan 15 2020
91.60
Average
20.52
Median
Oct 18 2021
Price Benchmarks
Viking Therapeutics Inc | 62.30 |
AN2 Therapeutics Inc | 1.99 |
NovaBay Pharmaceuticals Inc | 3.44 |
Palatin Technologies Inc | 1.80 |
iBio Inc | 2.38 |
Price Related Metrics
PS Ratio | 95.30 |
Price to Book Value | 0.4444 |
Earnings Yield | -223.1% |
Market Cap | 37.05M |